<DOC>
	<DOCNO>NCT00610324</DOCNO>
	<brief_summary>Oropharyngeal bacteria play important role pathogenesis nosocomial pneumonia critically ill patient . Oral cleanse chlorhexidine show decrease incidence pneumonia patient undergo open heart surgery . Its role critically ill general ICU patient yet prove . The present study proposes study effectiveness twice-daily oral cleanse 0.2 % chlorhexidine solution incidence nosocomial pneumonia ICU patient admit single intensive care unit Indian public hospital</brief_summary>
	<brief_title>Effect Oral Decontamination Using Chlorhexidine Potassium Permanganate ICU Patients</brief_title>
	<detailed_description>Nosocomial pneumonia common intensive care unit ( ICU ) patient associated increase mortality rate 24 % 76 % various study . Interventions effectively prevent nosocomial pneumonia strategically important order reduce morbidity , mortality healthcare cost . Colonization pharynx implicate reservoir pathogen cause nosocomial pneumonia intervention like selective digestive decontamination try control source infection . Recently , colonization dental plaque aerobic organisms subsequent aspiration lower respiratory tract receive attention . Previous small study use antiseptic agent sterilize dental plaque patient risk pneumonia show conflicting result . The present study aim determine whether twice daily oral cleanse 0.2 % chlorhexidine reduce incidence nosocomial pneumonia patient stay ICU &gt; 48 hour . After obtain informed consent , subject would randomize treatment either 0.2 % chlorhexidine gluconate ( CHG ) solution 0.01 % potassium permanganate solution ( PP ) ( Control Group ) , per protocol approve Institutional Ethics Committee . At baseline , parameter would note : age , sex , surgical non-surgical status , immunosuppression , chronic ailment , smoke alcohol consumption , Glasgow coma scale score ( GCS ) , laboratory parameter blood gas analysis . All subject would follow daily GCS , presence nasogastric tube ( feed ) , endotracheal tube , tracheostomy , ventilator , central venous urinary catheterization , anti-stress ulcer prophylaxis prior antibiotic use note . Presence absence nosocomial pneumonia would also noted daily . Lower respiratory secretion would obtain protected non-bronchoscopic mini-BAL technique order identify causative organism . All subject follow daily discharge ICU death . Primary outcome variable development nosocomial pneumonia ICU stay . Secondary outcome variable hospital mortality , length ICU stay . A total 506 patient study ( approximately 253 patient treatment group ) . This study statistical power 75 % detect 50 % reduction incidence nosocomial pneumonia intervention group 95 % level confidence assume incidence pneumonia control group 16 % .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Ventilator-Associated</mesh_term>
	<mesh_term>Pneumonia , Aspiration</mesh_term>
	<mesh_term>Chlorhexidine gluconate</mesh_term>
	<mesh_term>Chlorhexidine</mesh_term>
	<criteria>All patient admit medical intensive care unit expect stay ICU &gt; 48 hour Pregnant woman Patients nosocomial pneumonia time ICU admission Patients communityacquired pneumonia time ICU admission Patients oropharyngeal cleansing contraindicate</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>oropharyngeal cleanse</keyword>
	<keyword>oral decontamination</keyword>
	<keyword>oropharyngeal bacterial flora</keyword>
	<keyword>oropharyngeal colonization</keyword>
	<keyword>critical illness</keyword>
	<keyword>mechanical ventilation</keyword>
	<keyword>tracheal intubation</keyword>
	<keyword>prophylaxis</keyword>
</DOC>